Origen de la red de primer grado Chao Zhang.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA.
14
| Subsidiary | Miscellaneous Commercial Services | 14 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Chao Zhang a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| INTERMUNE INC | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Opna Bio SA
 Opna Bio SA Pharmaceuticals: GenericHealth Technology Opna Bio is a clinical-stage biopharmaceutical company located in the US that focuses on discovering and developing novel oncology therapeutics. Opna's lead clinical compound, opn-2853, a bromo and extra terminal (bet) domain inhibitor, is currently in a phase 1/2 trial with ruxolitinib (jakafi®) in myelofibrosis, a chronic bone marrow disorder. The American company's team has a proven track record of scientific expertise and commercial value creation, having advanced multiple FDA-approved drugs to market. The company has a broad portfolio that targets multiple drivers of cancer, including a novel oncology discovery program focused on the fragile-x mental retardation protein (fmrp) and a diversified pipeline of validated oncology assets acquired from plexxikon. | Pharmaceuticals: Generic | Founder Founder | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chairman | |
| IO BIOTECH, INC. | Biotechnology | Chairman Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| New York University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| Haas School of Business | College/University | Undergraduate Degree | |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| IBM | Packaged Software | Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director of Finance/CFO | |
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Yale School of Medicine | College/University | Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| European Molecular Biology Organization | Corporate Officer/Principal | ||
| Russian Academy of Sciences | College/University | Corporate Officer/Principal | |
| INOZYME PHARMA, INC. | Pharmaceuticals: Major | Founder | |
| Yale University | College/University | Corporate Officer/Principal | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| CARDINAL HEALTH, INC. | Medical Distributors | Corporate Officer/Principal | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Alignment Ventures LLC
 Alignment Ventures LLC Investment ManagersFinance Alignment Ventures LLC (Alignment Ventures) is a venture capital firm founded in 2011 by Michael Tippie. The firm is headquartered in Reno, Nevada. | Investment Managers | Private Equity Investor | |
| Rice University | College/University | Corporate Officer/Principal | |
| University of Victoria | College/University | Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Florida | College/University | Doctorate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CellGate Technologies LLC
 CellGate Technologies LLC Computer PeripheralsElectronic Technology Part of StarVox Communications, Inc., CellGate Technologies LLC is a company that manufactures integrated wireless IP modem adapters and provides wireless services. The company is based in Boca Raton, FL. The company was founded by Edgar G. Engleman. CellGate Technologies was acquired by U.S. Wireless Data, Inc. on November 17, 2000 for $2.23 million. | Computer Peripherals | Corporate Officer/Principal | |
| Weizmann Institute of Science | College/University | Doctorate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 39 |
| Dinamarca | 3 |
| Canadá | 3 |
| Suiza | 2 |
| Bélgica | 2 |
Sectorial
| Health Technology | 30 |
| Consumer Services | 11 |
| Electronic Technology | 3 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operativa
| Director/Board Member | 39 |
| Corporate Officer/Principal | 39 |
| Chief Tech/Sci/R&D Officer | 16 |
| Founder | 12 |
| Director of Finance/CFO | 12 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Chao Zhang
- Conexiones Empresas
